SDMHF News and Press, Sartorius Stedim Biotech From 09/19/23

2023-09-19 10:00:00 ET Summary I am a 24-year-old investor aiming for financial freedom through long-term investing in companies with good management and growth potential. I made changes to the portfolio, buying stocks such as UFP Industries and Ulta Beauty, and selling stocks lik...

2023-07-21 17:47:09 ET Sartorius Stedim Biotech S.A. (SDMHF) Q2 2023 Earnings Conference Call July 21, 2023 09:30 AM ET Company Participants Joachim Kreuzburg - CEO Rainer Lehmann - CFO René Fáber - Head, Bioprocess Solutions and CEO, Sartorius Stedim B...

2023-07-21 14:35:23 ET Sartorius Stedim Biotech S.A. press release ( OTCPK:SDMHF ): 1H GAAP EPS of €2.62. Revenue of €1.41B (-18.0% Y/Y). For further details see: Sartorius Stedim Biotech S.A. GAAP EPS of €2.62, revenue of €1.41B

2023-07-19 13:50:00 ET Summary Mawer Investment Management is a privately owned, independent investment firm, managing over $67B in assets for individual and institutional investors across all major asset classes. Globally, equity markets continued to be resilient in the second qu...

2023-07-01 03:47:27 ET Summary Sartorius has been experiencing a demand decline since 2022. Sartorius serves a niche market, which gives it a strong moat. Sartorius benefits from the long-term tailwinds of its sector. We will review all the negative factors that are curren...

2023-06-26 11:00:28 ET Summary The bioprocessing market is currently in a downturn and pulling companies like Danaher and Sartorius down. Danaher has a clean balance sheet to make good deals in this downturn. Margins have temporary headwinds but should recover in 2024. At ...

2023-06-20 05:46:45 ET Summary Sartorius AG's stock price fell over 15% after the company lowered its forecast significantly. Sartorius may also fail to achieve its 2025 revenue targets, despite reaffirming its guidance in that regard. The €2.4 billion acquisition of Po...

2023-04-03 13:00:00 ET Summary Sartorius announced the 2.4 billion euro acquisition of Polyplus. Polyplus is producing transfection reagents and generates <100 million euros in revenues. The acquisition appears to be very expensive and management has not explained the reaso...

2023-04-02 10:00:40 ET Summary In October I showcased my full portfolio. For my 100th Seeking Alpha article I decided to post an update and show how my portfolio developed. I sold out of 3 companies and added 6 new companies. I've contributed to Seeking Alpha for ove...

Sartorius Stedim Biotech S.A. (SDMHF) Q4 2022 Earnings Conference Call January 26, 2023, 09:30 AM ET Company Participants Joachim Kreuzburg - CEO Rainer Lehmann - CFO, Member of Executive Board Conference Call Participants Odysseas Manesiotis - Berenberg Ma...